Home
Alnylam Pharmaceuticals ALNY spent $220K on lobbying in Q3 2023 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $220,000
- Quarter
- Q3 2023
- Client
- Alnylam Pharmaceuticals
- Reported
- 23/10/20
$850K on lobbying this year
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/08/31~23/10/30Alnylam Pharmaceuticals's other lobbying reports
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$450K
$450K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/19
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$30K
$30K
Reported 07/16
for Q2